Exozymes (EXOZ) Profit After Tax (2023 - 2026)

Exozymes (EXOZ) has reported Profit After Tax for 3 consecutive years, with -$2.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Profit After Tax fell 44.61% year-over-year to -$2.7 million; the TTM figure through Dec 2025 stood at -$9.2 million (down 56.26% YoY), while the FY2025 annual figure was -$9.2 million, down 56.26% from the prior year.
• Profit After Tax eased to -$2.7 million in Q4 2025 per EXOZ's latest filing, from -$2.3 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$520596.0 in Q3 2023 and bottomed at -$2.7 million in Q4 2025.
• Historically, Profit After Tax has averaged -$1.7 million across 3 years, with a median of -$1.7 million in 2024.
• Annual changes were most pronounced in 2024 — Profit After Tax plunged 218.17% — and 2025, when it tumbled 38.07%.
• Exozymes' Profit After Tax stood at -$1.1 million in 2023, then tumbled by 67.12% to -$1.8 million in 2024, then sank by 44.61% to -$2.7 million in 2025.
• Business Quant data shows EXOZ's Profit After Tax at -$2.7 million in Q4 2025, -$2.3 million in Q3 2025, and -$2.4 million in Q2 2025.